Ophthalmic Therapeutics/Drugs Market Is Projected To Grow Rapidly Due To Increase In R&D For The Development Of Novel Entityare Till 2025: Grand View Research, Inc.

The global ophthalmic therapeutics/drugs market is expected to reach USD 35.7 billion by 2025, according to a new report by Grand View Research, Inc. Increase in funding by public and private bodies for conducting research on ocular disorders with the presence of strong emerging pipeline drugs are some of the factors responsible for the growth of ophthalmic therapeutics market. For instance, the recent approval of Zerviate (cetirizine) for the treatment of allergic conjunctivitis in 2017 and Humira (adalimumab) and Xiidra (lifitegrast) in 2016 as ophthalmic solutions for the treatment of uveitis and dry eyes are expected to boost the market growth.

Numerous ongoing public-private partnership agreements in the pharmaceutical industry for the development of novel therapeutics are expected to provide this market with lucrative growth opportunities. In the recent years, a number of highly-effective and safe agents have emerged for the treatment of fungal ophthalmic diseases. Natamycin, amphotericin B, clotrimazole, are some of the most promising therapeutics present in the market. For instance, in October 2016, Santen Pharmaceuticals, Foundation for Biomedical Research and Innovation (FBRI), and RIKEN announced a research collaboration to develop new treatments for retinal diseases such as age-related macular degeneration and retinitis pigmentosa.

U.S ophthalmic therapeutics/drug market, by class, 2014 - 2025 (USD Billion)




Browse full research report on Ophthalmic Therapeutics/Drugs Market: http://www.grandviewresearch.com/industry-analysis/ophthalmic-therapeutics-drug-market    
        
Further key findings from the report suggest:

  • Antiallergy is the largest segment owing to the increasing incidence of ocular infections, high prescription rate of antiallergy agents, and presence of a wide product portfolio
  • Retinal disorders segment dominated the market in 2016 due to increasing prevalence of age-related macular degenerations and diabetic retinopathy, its subtypes
  • The eye drops segment is anticipated to dominate the market in 2016. It is considered as the most preferred dosage form due to associated benefits such as easy assimilation, target-specific action, and faster recovery
  • Over-the-Counter (OTC) held the largest share in 2016 due to its low cost and increasing preference of OTC over prescription drugs
  • North America dominated the market in 2016 owing to factors such as the increase in demand for ophthalmic solutions for the treatment of glaucoma and dry eyes in this region.
  • Asia Pacific is anticipated to be the fastest growing region with a lucrative CAGR during the forecast period due to rising disposable income, presence of a large population base, and growing awareness programs by various organizations.
  • Some of the key players in this industry are Allergan; Aerie Pharmaceuticals, Inc.; Pfizer Inc.; Valeant Pharmaceuticals International, Inc.; Bayer AG; Genentech, Inc.; Novartis AG; Regeneron Pharmaceuticals, Inc.; Shire; and Santen Pharmaceutical Co., Ltd.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/pharmaceuticals   
                 
Grand View Research has segmented the global ophthalmic therapeutics/drugs market on the basis of class, disease, dosage form, product, and region:

Drug Class Outlook (Revenue, USD Million; 2014 - 2025)
  • Antiallergy
  • Anti-Vascular Endothelial Growth Factor (Anti-VEGF) agents
  • Anti-inflammatory
    • Nonsteroidal drugs
    • Steroidal drugs
  • Antiglaucoma
  • Others
Disease Outlook (Revenue, USD Million; 2014 - 2025)
  • Dry Eye
  • Allergies
  • Glaucoma
  • Inflammation/Infection
  • Retinal Disorders
  • Uveitis
  • Others
Dosage form Outlook (Revenue, USD Million; 2014 - 2025)
  • Gels
  • Eye solutions
  • Capsules & Tablets
  • Eye drops
  • Ointments
Product Outlook (Revenue, USD Million; 2014 - 2025)
  • Prescription drugs
  • OTC drugs
Regional Outlook (Revenue, USD Million; 2014 - 2025)
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa 


Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-ophthalmic-therapeutics-drug-market   
                              
About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.


For more information: http://www.grandviewresearch.com

Comments

Post a Comment

Popular posts from this blog

The global vein illuminator market is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future. The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, and ultrasound. The near-infrared illumination technology is estimated to be the largest shareholder due to its ability to penetrate deep into the tissue, which makes it possible to visualize the vessels clearly. On the basis of application, the market is segmented into intravenous access and blood draw. The end-user segment comprises hospitals, rehabilitation facilities, blood donation camps, and academic institutions. The market for hospitals is expected to grow rapidly during the forecast period due to a surge in the demand for technologically advanced medical equipment. The market is also categorized into North America, Europe, Asia Pacific, MEA, and Latin America. Browse full research report on global Vein Illuminator Market: http://www.grandviewresearch.com/industry-analysis/vein-illuminator-market Further key findings from the study suggest: • In terms of market share, the North America vein illuminator market is expected to hold majority of the share in 2016. Factors resulting in the growth of this industry are the steady preference for highly-advanced medical devices by hospitals as well as the presence of several medical device manufacturing companies in the region. • The infrared illumination technology is estimated to lead the industry due to its deep penetration capability into thick tissues tohighlight the presence of vessels with increased clarity. Based on application, the segment for intravenous access is estimated to be the largest shareholder, followed by the blood draw segment. • The vein illuminator industry comprises several local as well as global players. Some prominent players in this industry include Accuvein, Inc., Christie Medical Holdings, Inc., Infrared Imaging Systems, Inc., Translite, LLC, and Venoscope, LLC,among others. In order to hold a major share in the industry, the companies are adopting both organic as well as inorganic strategies. The major strategies adopted by the companies are new product development, mergers, collaborations, partnerships, geographical expansions, and acquisitions. • The companies are also focusing on research and development activities in order to enhance their product portfolio. For instance, in September 2015, Accuvein, Inc., declared its 26th patent, which was issued by the United States Patent and Trademark office for their vein visualization system. Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices Grand View Research has segmented the vein illuminator market on the basis of technology, application, and end-user application: Vein Illuminator Technology Outlook (Revenue, USD Million, 2013 - 2024) • Transillumination • Infrared technology • Others Vein Illuminator Application Outlook (Revenue, USD Million, 2013 - 2024) • Intravenous access • Blood draw • Others Vein Illuminator End-user Outlook (Revenue, USD Million, 2013 - 2024) • Hospitals • Blood donation camps • Academic institutions • Others Vein Illuminator Regional Outlook (Revenue, USD Million, 2013 - 2024) • North America • Europe • Asia Pacific • Latin America • MEA Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-vein-illuminator-market About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc For more information: www.grandviewresearch.com

The global  vein illuminator market  is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future. The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, a...
Read more

Hyaluronic Acid Market Is Likely To Be Influenced By The Increase In Obesity Till 2024: Grand View Research, Inc.

Image
The global  hyaluronic acid market   is expected to reach USD 13.4 billion by 2024, according to a new report by Grand View Research. Factors such as increasing concern in population regarding chemicals, desire to get quick and evident results, and shorter recovery time are high impact-rendering drivers of this market.  The market is evolving rapidly due to the increasing adoption of aesthetic procedures in both developed and developing regions. The growing geriatric population coupled with growing awareness about antiaging products and aspiration to look healthy and young is fueling the market for all cosmetics. The efficacy and evident results of hyaluronic acid - based dermal fillers are attracting this population base.  The increase in obesity resulting in osteoarthritis and joint pain has boosted the demand for hyaluronic acid injections as treatment. In 2012, approximately 53 million people were diagnosed with osteoarthritis and it is projected that b...
Read more

Protein Purification & Isolation Market Is Predicted To Grow Swiftly Due To Increased Research In The Fields Of Biotechnology & Pharmaceuticals Till 2025: Grand View Research, Inc.

Image
The global  protein purification and isolation market  is expected to be USD 9.5 billion by 2025, based on a new report by Grand View Research, Inc. Increased funding from both public and private research organizations for research and development of structure-based drugs and technological advancements are key drivers for the market.  Demand is increasing for the development of protein purification products based on single use purification process owing to increased proteomics research and rising need to identify new protein-based ligands with high specificity. Availability of a wide range of novel resins specific for different end users is estimated to be one of the drivers increasing the adoption rate of protein purification techniques. U.S. protein purification & isolation market, by technology, 2014 - 2025 (USD Billion) Browse full research report on Protein Purification & Isolation Market: http://www.grandviewresearch.com/industry-analysi...
Read more